Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 1.74 cents. At the last ...
After several examples of undisclosed alterations in reagent suppliers’ antibody catalogues surfaced, researchers call for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results